| Ytd | 27.51% | |
| 1y | 110.14% |
| Open | 2.53 | Prev Close | 2.52 | Low | 2.52 | High | 2.65 | Mkt Cap | 529.37M |
| Vol | 1.21M | Avg Vol | 2.73M | EPS | -0.05 | P/E | -52.43 | Forward P/E | -22.57 |
| Beta | 1.81 | Short Ratio | 4.10 | Inst. Own | 79.22% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 2.80 | 200-d Avg | 2.25 | 1yr Est | 3.90 |
U.S. stock futures rise, Nasdaq 100 up 300 points. Apple Inc shares fall 7.4% despite beating analys
Cerus Corporation (CERS) Q2 2026 Earnings Call Transcript
Cerus NASDAQ: CERS reported second-quarter product revenue growth of 10% year over year and raised t
Gainers Scribe Therapeutics (NASDAQ:SCTX) shares increased by 12.7% to $23.0 during Thursday's
Cerus (NASDAQ:CERS) reported quarterly losses of $(0.01) per share which met the analyst consensus e
Cerus (NASDAQ:CERS) raises FY2026 sales outlook from $227.000 million-$231.000 million to $229.000 m
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today financial results
Amova Asset Management Americas Inc. reduced its stake in shares of Cerus Corporation (NASDAQ: CERS)
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its second q
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001020214/000102021426000015/cers-20260706.htm
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today a company-sponsor
On Wednesday, June 10, 2026, Ark Invest sold $7.8M in Robinhood shares Wednesday while adding 141,50
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today the closing of a
HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff, a significant shareholder of Cerus Corporation (NASDAQ:
Health care stocks flashing warning for momentum investors. RSI measures stock strength, overbought
Cerus' Q1 2026 product revenues grew another 24% YoY. This was mainly thanks to strong platelet dema
Stocks AVNS, APLS, and CERS in healthcare sector flashing warning to momentum-sensitive investors. H
Top analysts upgraded APD, CAT, CERS, PPC, and HSY stocks with increased price targets. Check out an
Cerus Corporation (CERS) Q1 2026 Earnings Call Transcript
Cerus (NASDAQ:CERS) raises FY2026 sales outlook from $224.000 million-$228.000 million to $227.000 m
Cerus (NASDAQ:CERS) reported quarterly losses of $(0.01) per share which beat the analyst consensus
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today financial results
The EFS distributes approximately 330,000 units of platelets annually across 13 regional centers in
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today the signing of a
Cerus (NASDAQ: CERS - Get Free Report) and Akanda (NASDAQ: AKAN - Get Free Report) are both small-ca
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its first qu
Cerus Corporation (NASDAQ: CERS - Get Free Report) CFO Kevin Dennis Green sold 127,544 shares of the
Cerus Corporation (NASDAQ: CERS - Get Free Report) COO Vivek Jayaraman sold 165,200 shares of the st
Cerus Corporation (NASDAQ: CERS - Get Free Report) insider Chrystal Jensen sold 113,008 shares of th
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced that Vivek Jayara
Cerus (NASDAQ: CERS) executives used a presentation and fireside chat at the TD Cowen Healthcare Con
CERS' INTERCEPT platform (kits + illuminators) is scaling globally, with record 2025 results. They'v
MDB stock fell 27.2% in pre-market trading after reporting Q4 earnings of $1.65 per share, revenue o
Cerus (NASDAQ:CERS) affirms FY2026 sales outlook from $224.000 million-$228.000 million to $224.000
Cerus (NASDAQ:CERS) reported quarterly losses of $(0.01) per share which met the analyst consensus e
Preliminary Full-Year 2025 Product Revenue of $206.1 MillionFull-Year 2026 Product Revenue Expected
Cerus Corporation (NASDAQ:CERS) announced today that it has entered into a group purchasing agreemen
Cerus (NASDAQ:CERS) reported quarterly earnings of $0.00 per share which beat the analyst consensus
Cerus (NASDAQ:CERS) raises FY2025 sales outlook from $200.000 million-$203.000 million to $202.000 m